RSUs vs. Stock Options: A Life Sciences Founder’s Guide
wpdemosites
April 1, 2026
The equity compensation strategy that launched your biotech company in 2024 requires careful re-evaluation in 2026. Two years ago, your
The equity compensation strategy that launched your biotech company in 2024 requires careful re-evaluation in 2026. Two years ago, your
Building a tech or biotech startup requires assembling a world-class team. To attract top-tier engineers, clinical scientists, and seasoned executives,
Receiving restricted stock in your own startup is an exciting milestone for any founder. However, when that equity grant is
Summary for Founders Use stock options to conserve cash and retain talent Set the exercise price at fair market value
Summary for Founders NDA templates miss evolving confidential information, trade secrets and intellectual property (“IP”) realities. Templates often ignore improvements,
Summary for Founders Treat an NDA breach as an incident and act fast to stop further disclosure of confidential information.